Jupiter "disappointed" at AstraZeneca's rejection of Pfizer bid
May 19, 2014 at 06:04 AM EDT
LONDON, May 19 (Reuters) - Britain's Jupiter Fund Management , a top-30 shareholder in UK pharmaceuticals giant AstraZeneca, said it is disappointed with the firm's rejection of U.S. rival Pfizer 's final takeover offer.
